The IPO Buzz: Kyverna Therapeutics Prices Upsized IPO at $22.00 – $1.00 Above Range
Clinical biotech Kyverna Therapeutics (KYTX) priced its upsized IPO at $22.00 – $1.00 above its recently increased range – on 14.5 million shares – the number of shares in the prospectus – to raise $319 million on Wednesday night (Feb. 7, 2024). The $22.00 IPO price exceeded Kyverna’s price range of $20.00 to $21.00, which was disclosed on Tuesday […]
February 8, 2024 Read More